Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marilyn K Glassberg

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
American Journal of Respiratory and Critical Care Medicine|August 3, 2013
To be or not to be a neoplasm: what is lymphangioleiomyomatosis? Are we calling it what it really is?Marilyn K Glassberg
The American Journal of Managed Care|August 17, 2019
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscapeMarilyn K Glassberg
Clinics in Chest Medicine|August 28, 2004
LymphangioleiomyomatosisMarilyn K Glassberg
Critical Care Nursing Clinics of North America|August 23, 2025
Managing Acute Exacerbations in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in the Intensive Care Unit SettingAlissa Ali, Marilyn K Glassberg
Annals of the American Thoracic Society|February 21, 2019
Multipotent Mesenchymal Stromal Cells and Lung Disease: Not Ready for Prime TimeStefanie Purdon, Marilyn K Glassberg
American Journal of Respiratory and Critical Care Medicine|December 22, 2005
Lymphangioleiomyomatosis: a national registry for a rare diseaseAnne E Tattersfield, Marilyn K Glassberg
Respirology (Carlton, Vic.)|August 16, 2014
Moving stem cell therapy to patients with idiopathic pulmonary fibrosisMarilyn K Glassberg, Rebecca L Toonkel
Frontiers in Medicine|November 19, 2019
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease ManagementMehdi Mirsaeidi, Pamela Barletta, Marilyn K Glassberg
American Journal of Respiratory and Critical Care Medicine|May 1, 2024
The Controversy Continues: Whether to Perform Plasma Exchange, and with What Dose of Steroids, in the PEXIVAS TrialMarilyn K Glassberg, Alissa Ali, Gina Gregorini
The American Journal of the Medical Sciences|April 24, 2019
Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?Stefanie Purdon, Carissa L Patete, Marilyn K Glassberg
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
American Journal of Respiratory and Critical Care Medicine|August 3, 2013
To be or not to be a neoplasm: what is lymphangioleiomyomatosis? Are we calling it what it really is?Marilyn K Glassberg
The American Journal of Managed Care|August 17, 2019
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscapeMarilyn K Glassberg
Clinics in Chest Medicine|August 28, 2004
LymphangioleiomyomatosisMarilyn K Glassberg
Critical Care Nursing Clinics of North America|August 23, 2025
Managing Acute Exacerbations in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in the Intensive Care Unit SettingAlissa Ali, Marilyn K Glassberg
Annals of the American Thoracic Society|February 21, 2019
Multipotent Mesenchymal Stromal Cells and Lung Disease: Not Ready for Prime TimeStefanie Purdon, Marilyn K Glassberg
American Journal of Respiratory and Critical Care Medicine|December 22, 2005
Lymphangioleiomyomatosis: a national registry for a rare diseaseAnne E Tattersfield, Marilyn K Glassberg
Respirology (Carlton, Vic.)|August 16, 2014
Moving stem cell therapy to patients with idiopathic pulmonary fibrosisMarilyn K Glassberg, Rebecca L Toonkel
Frontiers in Medicine|November 19, 2019
Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease ManagementMehdi Mirsaeidi, Pamela Barletta, Marilyn K Glassberg
American Journal of Respiratory and Critical Care Medicine|May 1, 2024
The Controversy Continues: Whether to Perform Plasma Exchange, and with What Dose of Steroids, in the PEXIVAS TrialMarilyn K Glassberg, Alissa Ali, Gina Gregorini
The American Journal of the Medical Sciences|April 24, 2019
Multipotent Mesenchymal Stromal Cells for Pulmonary Fibrosis?Stefanie Purdon, Carissa L Patete, Marilyn K Glassberg
Pageof 9